European data project seeks to harmonize 100 million health records

23 November 2018
pharma_data_big

A new pharma-partnered project has been set up to build a large-scale, federated network of data sources standardized to a common model.

The European Health Data & Evidence Network (EHDEN), a public-private project, will operate in Europe for the coming five years.

It was set up under the framework of the Innovative Medicines Initiative, co-funded by the trade association EFPIA and the European Commission, with 22 partners, including academia, SMEs, patient associations, regulatory authorities and pharma companies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical